Article and Video CATEGORIES

Cancer Journey

Search By

Ketki Patel, MHA, is a Program Operations Specialist/Post Award Specialist for the University of Washington Thoracic, Head and Neck Oncology Research Program in Seattle, Washington.

Ketki is an experienced Patient Financial Advocate with a demonstrated history of working with clinical trials/research, medical oncology, and holds knowledge in prior authorization of inpatient and outpatient chemotherapy and appealing all types of claim denials. She has experience working with the drug manufacturers for drug assistance and copay assistance in the hospital billing setting.

Covid-19 Financial Impacts and Resources for the Cancer Patient
Author
Ketki Patel, MHA, GRACE Guest Contributor
Covid-19 Financial Impacts and Resources for the Cancer Patient

As many of you know, the costs of treating a new disease or virus are often astronomical, and most insurance companies are in flux as they incorporate these therapies into their step therapies and tier programs, and work to come up with medical necessity criteria to allow coverage for experimental treatments.

There are many potential financial impacts and, as a result, many resources emerge to help mitigate these impacts. Thanks to the wide array of organizations dedicated to helping people dealing with cancer, resources have been extended to assist with some costs associated with Covid-19. The list below is just a few of the many options available; I highly recommend working with a financial advocate to see what may be available specifically in your area as well.

Lymphoma and Leukemia Assistance
Breast Cancer Assistance
Colorectal Cancer Assistance
Lung Cancer Assistance

 

Medicare currently provides coverage for the following Covid-19 related services:

  • Medicare Part B will cover the coronavirus or Covid-19 test done to determine whether or not someone is positive for the virus itself https://www.medicare.gov/coverage/coronavirus-disease-2019-covid-19-tes…
  • Medicare Part B will cover any FDA approved antibody or serology (blood serum) tests
  • Medicare Part A will cover any medically necessary hospital stays for Covid-19, including if someone is diagnosed with Covid-19 and might otherwise have been discharged from the hospital after the hospitalization/inpatient stay, but needs to stay in the hospital under quarantine. A patient would still pay for any hospital deductibles, copays, or coinsurances that apply.

 

One other item that has probably changed drastically is the venue in which you see your doctor. Many providers have switched to telehealth visits, or visits through a video conferencing platform like Zoom or Skype. With that comes a plethora of medical necessity criteria as well that insurance companies need to account for. It looks like Medicare is following suit and has posted on their website that they will cover virtual visits at 80% under Medicare Part B, and the remaining 20% and/or deductible will default to patient responsibility.

Telehealth coverage varies by state, some states are integrating more coverage on their insurance plans as well. For example, Oregon recently announced that their commercial plans should provide expanded access to telehealth visits through the end of the year. It is always important to call your provider’s office to see if they offer the option and to check with your insurance company if they provide telehealth coverage and in what circumstances, a price estimate, and some insurance companies may even offer a free advice line as well. I have provided a link below that may help identify what’s available for telehealth options.

Oregon specific:

 

As policies are being created and insurance companies determine how to pay for these situations, I highly recommend reaching out to the insurance commissioner to ensure insurance companies are handling these claims appropriately. Many insurance commissioners have been pushing for insurer flexibility in light of the recent increase in health emergencies, and I recommend working with a financial advocate to pursue this route.

 

Lastly, there are currently several clinical trials that are monitoring Covid-19 and patients with cancer.  Clinicaltrials.gov is a great resource to see if there are any trials in your area.

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on